Insider Sale: CVP & Pres. Mission Systems of $NOC Sells 991 Shares

Roshan Roeder, CVP & President of Mission Systems at Northrop Grumman ($NOC), sold 991 shares on June 4, 2025, for approximately $485,590, representing a significant portion (75.7%) of their holdings; this sale is part of a broader trend of insider selling at $NOC over the past six months. Institutional investors showed mixed sentiment in Q1 2025, with some firms like Wellington and T. Rowe Price substantially increasing their positions, while others such as JPMorgan Chase and FMR LLC reduced their holdings. Recent analyst ratings are generally positive, with Wells Fargo, Morgan Stanley, and Susquehanna issuing buy ratings and a median price target of $550.0.

Analysis

Northrop Grumman ($NOC) has experienced significant insider selling, highlighted by Roshan S Roeder, CVP & President of Mission Systems, divesting 991 shares, or 75.7% of their holdings in that class, for an estimated $485,590 on June 4, 2025. This individual action is part of a broader pattern within the past six months, during which $NOC insiders executed 64 sales and no purchases; notable sales include 3,750 shares by Chair, CEO and President Kathy J Warden for approximately $1.78 million. This consistent selling pressure from top management, contributing to a mildly negative sentiment signal (-0.2 for $NOC), contrasts with mixed institutional sentiment observed in Q1 2025. While 758 institutions added to their $NOC positions and 780 reduced them, prominent firms such as Wellington Management Group LLP increased holdings by 974,633 shares (+23.4%) and T. Rowe Price Investment Management, Inc. made a substantial addition of 935,554 shares (+1425.2%). Conversely, JPMorgan Chase & Co. reduced its stake by 865,682 shares (-23.1%). Despite the insider sales, Wall Street analysts remain optimistic, with three firms (Wells Fargo, Morgan Stanley, Susquehanna) issuing buy-equivalent ratings in recent months and a median price target of $550.0, suggesting potential upside from the approximate $490 per share price derived from Roeder's transaction. A minor congressional sale of up to $15,000 by Representative Josh Gottheimer was also reported in the last six months.

Key Decisions for Investors

• Investors should carefully evaluate the persistent and broad-based insider selling at $NOC, including by top executives, as a significant cautionary signal warranting close scrutiny of the company's near-term outlook.
• The divergence in Q1 2025 institutional activity, with major firms like Wellington and T. Rowe Price increasing stakes while others like JPMorgan significantly reduced positions, necessitates thorough due diligence to understand the conflicting market perspectives.
• While recent analyst ratings are uniformly positive with a median price target of $550.0 suggesting upside, these should be carefully weighed against the strong insider selling trend before making or adjusting investment positions in $NOC.